Evidence map›Paper›PMID 42796563›Full record

ArticleMolecules (Basel, Switzerland)2026

Quantum Theoretical, Chemo-Computational, and Comparative Molecular Coupling Studies of Two Enantiomeric Naphthoquinones, Alkannin and Shikonin, and Their Corresponding Indole Derivatives.

Adriana Lizbeth Rivera Espejel, Sebastian Buendia Lira, René Miranda Ruvalcaba, René Gerardo Escobedo-González, Miguel Cuevas-Cruz, Alberto A Fajardo de la Rosa, David A Nieto-Álvarez, Joel Martínez, María Inés Nicolás-Vázquez

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adriana Lizbeth Rivera EspejelFacultad de Estudios Superiores Cuautitlán, Departamento de Ciencias Químicas, Campo 1, Universidad Nacional Autónoma de México, Cuautitlán Izcalli 54740, Mexico.ORCID 0000-0001-7951-1361
Sebastian Buendia LiraFacultad de Estudios Superiores Cuautitlán, Departamento de Ciencias Químicas, Campo 1, Universidad Nacional Autónoma de México, Cuautitlán Izcalli 54740, Mexico.
René Miranda RuvalcabaFacultad de Estudios Superiores Cuautitlán, Departamento de Ciencias Químicas, Campo 1, Universidad Nacional Autónoma de México, Cuautitlán Izcalli 54740, Mexico.
René Gerardo Escobedo-GonzálezDepartamento de Mantenimiento Industrial y Nanotecnología, Universidad Tecnológica de Juárez, Ciudad Juárez 32695, Mexico.ORCID 0000-0002-0640-0705
Miguel Cuevas-CruzDepartamento de Oceanografía Biológica, Centro de Investigación Científica y de Educación Superior de Ensenada (CICESE), Ensenada 22860, Mexico.ORCID 0000-0001-9921-5930
Alberto A Fajardo de la RosaLaboratorio de Ingeniería Química, Facultad de Química, Universidad Nacional Autónoma de México, Alcaldía Coyoacán, Ciudad de México 04510, Mexico.
David A Nieto-ÁlvarezInstituto Mexicano del Petróleo, Eje Central Lázaro Cárdenas Norte 152, San Bartolo Atepehuacan, Ciudad de México 07730, Mexico.
Joel MartínezFacultad de Estudios Superiores Cuautitlán, Departamento de Ciencias Químicas, Campo 1, Universidad Nacional Autónoma de México, Cuautitlán Izcalli 54740, Mexico.ORCID 0000-0002-6683-6738
María Inés Nicolás-VázquezFacultad de Estudios Superiores Cuautitlán, Departamento de Ciencias Químicas, Campo 1, Universidad Nacional Autónoma de México, Cuautitlán Izcalli 54740, Mexico.

Funding

Consejo Mexiquense de Ciencia y Tecnología EESP2025-0057
6 · The paper itself

Abstract

The use of computational tools has become widespread in drug discovery as an effective approach to guide the development of new therapeutic agents, including potential cancer drugs. In addition, plant-derived secondary metabolites have attracted considerable interest as a valuable source of bioactive compounds. Among these, alkannin and shikonin, two enantiomeric phyto naphthoquinones, have emerged as promising candidates for cancer therapy because of their anti-inflammatory properties and their ability to induce oxidative DNA damage in malignant cells. Related to the above commentaries, in the present study, the phyto naphthoquinones alkannin, shikonin, and their corresponding indole derivatives were evaluated employing density functional theory (DFT), followed by chemoinformatic analyses and molecular docking studies to evaluate, in silico, their potential activity against the cancer-related enzymes PARP-1, COX-2, and HDAC2, which are overexpressed in several types of cancer. The presence of the indole moiety in the phytomolecules increased their chemical reactivity, as exhibited by the calculated properties and the smaller LUMO-HOMO energy gap. In addition, the bioinformatic evaluation predicted that the target molecules may act as potential apoptosis agonists and antineoplastic agents. Finally, the performed molecular docking analysis suggested a stereoselective effect on the stability of ligand-protein binding complexes, particularly for alkannin, including relevant interactions with His201 and its indole derivative displaying interactions with His201, Tyr235, and Glu327 from the PARP-1 catalytic triad. Additionally, alkannin (-11.2 kcal/mol) and the corresponding indole derivative of shikonin (-10.14 kcal/mol) showed better interaction energies with COX-2 than naproxen (-8.75 kcal/mol). In the latter case, the inclusion of the indole moiety improved the binding affinity. In contrast, the affinity of the target compounds for HDAC2 decreased considerably with the indole derivatives in comparison with the reference compound BIZ.

Indexed as

IndolesNaphthoquinonesCyclooxygenase 2HumansMolecular Docking SimulationMolecular StructurePoly (ADP-Ribose) Polymerase-1Quantum TheoryStereoisomerismalkanninCyclooxygenase 2IndolesNaphthoquinonesPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1PTGS2 protein, humanshikoninalkanninCOX-2DFTHDAC2indole derivativesin silicomolecular dockingPARP-1shikonin

Identifiers

PMID42796563
PMCPMC13609537

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.